$CPAY

Orbis group (CPAY) discloses 5.4M Corpay shares under management in 13G/A

Orbis Investment Management Limited, Orbis Investment Management (U.S.), L.P., and Allan Gray Australia Pty Ltd filed Schedule 13G/A (Amendment No. 9) for Corpay, Inc. (CPAY). They report 5,408,507 Corpay shares beneficially owned, about 8.3% of the outstanding class. Orbis Investment Management Limited holds 5,053,072 shares (7.7%), with sole voting and dispositive power.

Original reporting
Published Aug 14, 2026, 5:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 15, 2026, 12:27 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CPAY
Neutral
medium confidence
Mentioned
$CPAY
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CPAYNeutralLow
01

Why it matters

Traders may use the disclosed stake size and sole voting/dispositive power to update ownership concentration and potential governance risk, but there is no stated operational or strategic action in the text.

02

Market read

Ownership transparency update for CPAY, with a sizable 8.3% aggregate stake and sole control rights reported by the main adviser entity.

03

What to watch

The filing is an amendment (No. 9) and includes disclaimers about group membership for Section 13(d)(3), which can reduce the likelihood of near-term control-related action.

Relevance 4/10Novelty 4/10Timing: as of the 13G/A filing date, investors may reassess ownership/control positioning

Background

The article summarizes a Schedule 13G/A (Amendment No. 9) beneficial ownership disclosure for Corpay, Inc. by Orbis Investment Management and Allan Gray Australia.

Company-level read

Ticker impact

$CPAYNeutralMedium confidence
Context

Orbis and Allan Gray filed Schedule 13G/A showing 5,408,507 Corpay shares, 8.3% of the class, with sole voting and dispositive power reported.

Expected impact

Near-term price impact is likely limited unless traders interpret the 8.3% stake as a new activism or control signal; otherwise it should be absorbed as routine 13G/A reporting.

Evidence & confidence

The article provides a new SEC filing snapshot (Amendment No. 9) with aggregate stake size and control rights, but it contains no deal, governance action, or fundamental catalyst beyond ownership transparency.

Market effects

Could marginally influence sentiment around corporate governance and ownership concentration in the payments/financial services space, but no sector-wide policy or competitive event is disclosed.

No direct regional market linkage beyond the filing’s international adviser entities.

Limited global relevance; this is a single-issuer ownership disclosure with no cross-border transaction described.

Counterpoint

An 8.3% 13G/A stake may reflect passive or investment-management positioning rather than any intent to influence strategy, so the market may overreact to control narratives.

Key entities

  • Corpay, Inc.

    Subject of the Schedule 13G/A disclosure, with Orbis and Allan Gray reporting 5,408,507 shares (8.3% of the class).

  • Orbis Investment Management Limited

    Reports sole voting and dispositive power over 5,053,072 shares (7.7% of the class).

  • Orbis Investment Management (U.S.), L.P.

    Reports sole voting and dispositive power over 352,118 shares (0.5% of the class).

  • Allan Gray Australia Pty Ltd

    Reports sole voting and dispositive power over 3,317 shares (rounded to 0% of the class).

Related articles

$CPAYMed

Corpay (CPAY) Just Posted A Record Quarter, So Why The Caution?

Corpay (NYSE:CPAY) reported Q2 2026 revenue of $1.34 billion, up 21% year over year and $45 million above expectations, with cash EPS of $7.00, up 36%. The company raised full-year guidance to $5.31 billion revenue and $27.35 cash EPS midpoint, citing growth in Corporate and Vehicle Payments, plus Alpha and Avid contributions, while noting a $100 million FTC-related charge and an Epics divestiture.

$CPAYMedAI 8/10

Corpay (CPAY) Q2 2026 Earnings Call Transcript

Corpay (NYSE:CPAY) reported Q2 2026 revenues of $1.34B, up 21%, and adjusted net income per diluted share of $7.00, up 36% year over year. Management guided FY2026 revenue to $5.29B-$5.33B and adjusted EPS to $27.15-$27.55, plus FCF of about $1.8B. The quarter included a $100M FTC settlement charge and $321M in share repurchases.

$CPAYHighAI 9/10

Corpay Q2 Earnings Call Highlights

Corpay (NYSE:CPAY) raised full-year revenue guidance to $5.31B at the midpoint (+17% vs 2025) and adjusted EPS to $27.35 (+28%). Q2 results included a $45M revenue beat; guidance reflects improved macro and momentum, partly offset by an epyx sale expected to close in fall. Q3 revenue midpoint is $1.355B, adjusted EPS $7.15.

$CPAYMedAI 8/10

Corpay: Q2 Earnings Snapshot

Corpay, Inc. (CPAY) reported Q2 net income of $248.3 million, or $3.70 per share. Adjusted earnings were $7.00 per share versus a Zacks estimate of $6.60. Revenue was $1.34 billion versus $1.31 billion expected. Corpay forecast full-year earnings of $27.15 to $27.55 per share and revenue of $5.29 to $5.33 billion.